Product Lines

Quantitative Upconversion Reporter (QU) product portfolio

01

QURapid UCP

Platform: Singleplex lateral flow assay
Targets: αIgM PGL-I antibody, CAA carbohydrate, IFN-γ protein
Diseases: Leprosy, Schistosomiasis, Extrapulmonary TB

02

QUSignature

Platform: UCP multiplex lateral flow assay
Markers: 2-marker (CRP, PCT, SAA1/2), 3-marker (CRP, IP-10, SAA1), 4-marker (CRP + PCT)
Use Case: Active tuberculosis triage

03

QUDiverse

Platform: UCP microtiter-based assay
Capabilities: Custom plates, Lyospheres, Flexible assay formats
Status: Pipeline product

Discover More

Technology & Services

We design and develop quantitative diagnostic and monitoring solutions tailored to your needs.

01

Upconverting Particle Technology

Luminescent UCP reporters enable sensitive, low-background detection with superior signal-to-noise ratios.

High signal-to-noise Low background Quantitative readout
02

Custom Assay Design

From concept to validated assay, we partner with you through every stage of development.

Feasibility studies Assay optimization Technology transfer
Work With Us

About Us

QDiaMon (pronounced "cue-dye-mon") develops quantitative diagnostic and monitoring solutions based on upconverting particle technology.

01
Founders
SB
Sherif Bayoumy, PhD
PC
Paul Corstjens, PhD
DI
David van IJzendoorn, MD, PhD
02
Publications

Prevalence of schistosome infection among children under two years of age: a brief report from medium-to-high endemic regions of Schistosoma mansoni in Madagascar

Irina Kislaya, Rivo Andry Rakotoarivelo, Tahimandranto Rasamoelina, Paul L A M Corstjens, Govert J van Dam, et al.; freeBILy consortium

Ready to collaborate?

Get in Touch

Let's build quantitative diagnostics together.

Book some time with us, or send us a message.

Our Calendar